Mechanisms of Cell Death in Spinal Muscular Atrophy
NCT01754441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2020-02-21
Summary
Spinal muscular atrophy is a genetically based disease that affects motor neurons in the spinal cord and leads to muscle wasting and weakness. The gene found to be responsible for the underlying disease is called the SMN or survival motor neuron gene. Individuals with SMA are either missing a copy of the gene or have a mutation in the gene. Although the gene has been identified, how it actually causes the motor neurons to die and leads to muscle wasting and weakness is not completely understood. The investigators have found that skin cells from children with SMA tend to be more susceptible to cell death when exposed to cell death inducing agents. In this protocol, The investigators wish to study the mechanisms by which these cells die when exposed to these agents and how this may be related to the gene defect and the disease.
Conditions
Sponsors & Collaborators
-
Nemours Children's Clinic
lead OTHER
Principal Investigators
-
Matthew ER Butchbach, Ph.D. · Nemours Biomedical Research
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2020-02-29
- Completion
- 2020-02-29
Countries
- United States
Study Locations
More Related Trials
-
UK SMA Patient Registry
NCT04292574 ·Status: RECRUITING
-
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
NCT04944940 ·Status: RECRUITING
-
Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy
NCT02124057 ·Status: COMPLETED
-
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NCT06562283 ·Status: RECRUITING ·Phase: NA
-
MAP THE SMA: a Machine-learning Based Algorithm to Predict THErapeutic Response in Spinal Muscular Atrophy
NCT05769465 ·Status: RECRUITING
-
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
NCT01736553 ·Status: COMPLETED
-
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study
NCT05839145 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Review of the Management and Outcomes of Children With SMA in the West Midlands During 2017-2022
NCT05994950 ·Status: RECRUITING
-
Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy
NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Newborn Screening for Spinal Muscular Atrophy (SMA) - a Proof of Principle Study Using Anonymised Blood Spots.
NCT05237544 ·Status: COMPLETED
-
Natural History of Spinal Muscular Atrophy Type 1 in Taiwan
NCT02466529 ·Status: COMPLETED
-
Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular Atrophy
NCT05518773 ·Status: COMPLETED
-
A Registered Cohort Study on SMA
NCT04010604 ·Status: RECRUITING
-
Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene
NCT02550691 ·Status: TERMINATED ·Phase: NA
-
A Trial of Hydroxyurea in Spinal Muscular Atrophy
NCT00485511 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
International SMA Patient Registry
NCT00466349 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
NCT05824169 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)
NCT01166022 ·Status: COMPLETED ·Phase: NA
-
Newborn Screening for Spinal Muscular Atrophy
NCT05481164 ·Status: COMPLETED
-
Spinal Muscular Atrophy Neonatal Screening Program
NCT06310421 ·Status: RECRUITING
-
Pediatric Spinal Muscular Atrophy (SMA) China Registry
NCT05042921 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)
NCT04576494 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Spinal Muscular Atrophy
NCT00443066 ·Status: COMPLETED
-
Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine
NCT05645250 ·Status: UNKNOWN
-
Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.
NCT02044029 ·Status: COMPLETED